Recent Finacing
Recent Raise
Genespire is a Milan-based biotech developing IV-administered immune-shielded lentiviral vector gene therapies that enable liver-based lifelong therapeutic protein production for pediatric inherited metabolic diseases and primary immunodeficiencies.